• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

FDA APPROVES VALTREX

The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Related Content
Melanoma Research Foundation and Glowbar Join Forces to Fight Skin Cancer
May 12th 2025

Melanoma Research Foundation and Glowbar Join Forces to Fight Skin Cancer

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
August 1st 2023

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Building Trust Through Cultural Competency in Aesthetic Dermatology
May 7th 2025

Building Trust Through Cultural Competency in Aesthetic Dermatology

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
March 26th 2022

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

Peter Lio, MD, Advocates for Personalized Pediatric Dermatology
May 5th 2025

Peter Lio, MD, Advocates for Personalized Pediatric Dermatology

OCT and D-OCT Imaging Reveal Distinct Vascular and Dermal Patterns in Skin Photoaging Phenotypes
May 2nd 2025

OCT and D-OCT Imaging Reveal Distinct Vascular and Dermal Patterns in Skin Photoaging Phenotypes

© 2025 MJH Life Sciences

All rights reserved.